Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result

Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result

<strong>Background:</strong> Blood biomarkers may aid in recruitment to clinical trials of Alzheimer’s disease (AD) modifying therapeutics by triaging potential trials participants for amyloid positron emission tomography (PET) or cerebrospinal fluid (CSF) Aβ and tau tests. <strong&g...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Westwood, S, Baird, AL, Hye, A, Ashton, NJ, Nevado-Holgado, AJ, Anand, SN, Liu, B, Newby, D, Bazenet, C, Kiddle, SJ, Ward, M, Newton, B, Desai, K, Hehir, C, Zanette, M, Galimberti, D, Parnetti, L, Lleó, A, Baker, S, Narayan, VA, Van Der Flier, WM, Scheltens, P, Teunissen, CE, Visser, PJ, Lovestone, S
Формат:	Journal article
Хэвлэсэн:	Frontiers Media 2018

Ижил төстэй зүйлс

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
-н: Sarah Westwood, зэрэг
Хэвлэсэн: (2018-12-01)

The influence of insulin resistance on CSF and plasma biomarkers of Alzheimer’s pathology
-н: Westwood, S, зэрэг
Хэвлэсэн: (2017)

New CSF biomarkers on the block
-н: Charlotte E Teunissen, зэрэг
Хэвлэсэн: (2016-09-01)

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
-н: Rosha Babapour Mofrad, зэрэг
Хэвлэсэн: (2019-12-01)

Determining the molecular pathways underlying the protective effect of non-steroidal anti-inflammatory drugs for Alzheimer's disease: A bioinformatics approach
-н: Nevado-Holgado, A, зэрэг
Хэвлэсэн: (2016)

CSF proteomic signature predicts progression to Alzheimer's disease dementia
-н: Eleonora M. Vromen, зэрэг
Хэвлэсэн: (2022-01-01)

Blood-based proteomic biomarkers of Alzheimer’s disease pathology
-н: Baird, A, зэрэг
Хэвлэсэн: (2015)

Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach
-н: Alejo J Nevado-Holgado, зэрэг
Хэвлэсэн: (2017-01-01)

CSF Proteomic Alzheimer’s Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
-н: Betty Marije Tijms, зэрэг
Хэвлэсэн: (2021-08-01)

Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET
-н: Yong-Jin Park, зэрэг
Хэвлэсэн: (2025-01-01)

Amyloid-Targeting PET Tracer [18F]Flutemetamol Accumulates in Atherosclerotic Plaques
-н: Sanna Hellberg, зэрэг
Хэвлэсэн: (2019-03-01)

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
-н: Teunissen, C, зэрэг
Хэвлэсэн: (2018)

Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population
-н: Lyduine E. Collij, зэрэг
Хэвлэсэн: (2023-11-01)

Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET
-н: Si Eun Kim, зэрэг
Хэвлэсэн: (2020-01-01)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
-н: Eline A. J. Willemse, зэрэг
Хэвлэсэн: (2021-01-01)

Variability of CSF Alzheimer's disease biomarkers: implications for clinical practice.
-н: Stephanie J B Vos, зэрэг
Хэвлэсэн: (2014-01-01)

Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross‐platform validation study
-н: Yanaika S. Hok‐A‐Hin, зэрэг
Хэвлэсэн: (2023-07-01)

Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's disease
-н: Winchester, L, зэрэг
Хэвлэсэн: (2018)

Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods
-н: Mark R. Battle, зэрэг
Хэвлэсэн: (2018-12-01)

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
-н: Charlotte E. Teunissen, зэрэг
Хэвлэсэн: (2018-03-01)

Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI.
-н: Vandenberghe, R, зэрэг
Хэвлэсэн: (2013)

Early-phase 18F-FP-CIT and 18F-flutemetamol PET were significantly correlated
-н: Young-Sil An, зэрэг
Хэвлэсэн: (2021-06-01)

Temporal and anatomical distribution of 18F-flutemetamol uptake in canine brain using positron emission tomography
-н: Taesik Yun, зэрэг
Хэвлэсэн: (2020-01-01)

PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases
-н: Juhan Reimand, зэрэг
Хэвлэсэн: (2019-12-01)

Blood-based biomarker candidates of cerebral amyloid using PiB PET in non-demented elderly
-н: Westwood, S, зэрэг
Хэвлэсэн: (2016)

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
-н: Vandenberghe, R, зэрэг
Хэвлэсэн: (2010)

Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
-н: Hugh G. Pemberton, зэрэг
Хэвлэсэн: (2023-05-01)

Automatic lesion detection and segmentation in 18F-flutemetamol positron emission tomography images using deep learning
-н: Chan Ju Ryu
Хэвлэсэн: (2022-12-01)

Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies
-н: Fiona Heeman, зэрэг
Хэвлэсэн: (2019-03-01)

Cross-sectional and longitudinal analyses of outdoor air pollution exposure and cognitive function in UK Biobank
-н: Cullen, B, зэрэг
Хэвлэсэн: (2018)

Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank
-н: Nevado-Holgado, A, зэрэг
Хэвлэсэн: (2016)

Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and CSF
-н: Winchester, L, зэрэг
Хэвлэсэн: (2022)

18F-flutemetamol PET/CT imaging in the diagnosis of mild cognitive impairment and Alzheimer's disease：a preliminary study
-н: LEI Zhe, зэрэг
Хэвлэсэн: (2022-07-01)

Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques
-н: Milos D. Ikonomovic, зэрэг
Хэвлэсэн: (2018-06-01)

Quantitative Evaluation of 18F-Flutemetamol PET in Patients With Cognitive Impairment and Suspected Alzheimer's Disease: A Multicenter Study
-н: Hiroshi Matsuda, зэрэг
Хэвлэсэн: (2021-01-01)

Blood based proteomic biomarkers of Alzheimer’s disease pathology
-н: Alison Louise Baird, зэрэг
Хэвлэсэн: (2015-11-01)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
-н: Carla M. Startin, зэрэг
Хэвлэсэн: (2019-03-01)

Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer’s disease
-н: Laura M. Winchester, зэрэг
Хэвлэсэн: (2018-06-01)

Synaptic protein CSF levels relate to memory scores in individuals without dementia
-н: Wesenhagen, KEJ, зэрэг
Хэвлэсэн: (2025)

Synaptic protein CSF levels relate to memory scores in individuals without dementia
-н: Kirsten E. J. Wesenhagen, зэрэг
Хэвлэсэн: (2025-03-01)